MAPT and Alzheimer disease: Taken together, nicotine may alleviate mitochondrial dysfunction, ROS formation and Aβ- and tau-induced inflammation in AD patients through activating α7 nAChRs and the PI3K/Akt signaling pathway, ultimately improving learning and memory functions.